Literature DB >> 10960643

Oral misoprostol and intracervical dinoprostone for cervical ripening and labor induction: a randomized comparison.

J L Bartha1, R Comino-Delgado, F Garcia-Benasach, P Martinez-Del-Fresno, L J Moreno-Corral.   

Abstract

OBJECTIVE: To compare efficacy, safety, and tolerance of oral misoprostol with intracervical dinoprostone for cervical ripening and labor induction.
METHODS: Two hundred women were randomized to receive single doses of oral misoprostol 200 microg or 0.5 mg of dinoprostone intracervically every 6 hours for a maximum four doses.
RESULTS: The intervals from administration of the drug to active phase of labor (11.1 hours [7-24] versus 15.8 hours [7.5-29.62], P =. 01), to delivery (14.0 hours [8.42-27.61] versus 20.2 hours [16.7-32. 8], P =.01), and to rupture of membranes (10.0 hours [4.95-24.7] versus 15.6 hours [8.2-29.2], P =.003) were significantly shorter in the misoprostol group. All those variables were not distributed normally, so results are presented as median and interquartile range. The rates of women who needed oxytocin (68% versus 52%, P =.03) and cesarean for failed induction (9% versus 1%, P =.01) were higher in the dinoprostone group.
CONCLUSION: A single dose of 200 microg oral misoprostol was more effective for cervical ripening and labor induction than 0.5 mg of dinoprostone intracervically every 6 hours, with a maximum of four doses.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10960643     DOI: 10.1016/s0029-7844(00)00954-6

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  3 in total

Review 1.  Oral misoprostol for induction of labour.

Authors:  Zarko Alfirevic; Nasreen Aflaifel; Andrew Weeks
Journal:  Cochrane Database Syst Rev       Date:  2014-06-13

2.  A randomized controlled trial of foley catheter, extra-amniotic saline infusion and prostaglandin e2 suppository for labor induction.

Authors:  Mandana Mansour Ghanaie; Mina Jafarabadi; Forozan Milani; Seyed Alaedin Asgary; Morteza Fallah Karkan
Journal:  J Family Reprod Health       Date:  2013-06

3.  A randomized controlled trial comparing isosorbide dinitrate-oxytocin versus misoprostol-oxytocin at management of foetal intrauterine death.

Authors:  Gabriel Arteaga-Troncoso; Aide E Chacon-Calderon; Francisco J Martinez-Herrera; Sylvia G Cruz-Nuñez; Marcela Lopez-Hurtado; Aurora Belmont-Gomez; Alberto M Guzman-Grenfell; Blanca E Farfan-Labonne; Carlos J Neri-Méndez; Francisco Zea-Prado; Fernando M Guerra-Infante
Journal:  PLoS One       Date:  2019-11-21       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.